Skip to main content
. 2020 Feb 4;105(3):e858–e870. doi: 10.1210/clinem/dgaa055

Table 5.

Adjusted mean heart rate (beats per minute, SE) by hemoglobin A1c level among adults with diagnosed diabetes age 20 years or older with diabetes, NHANES 2011 to 2016

Diagnosed Diabetes
HbA 1c <53 mmol/mol(<7.0%) (N = 1029)(Reference) HbA 1c 53 to <75 mmol/mol(7.0%-<9.0%)(N = 730) HbA 1c 65 to <97 mmol/mol(9.0%-<11.0%)(N = 217) HbA 1c 97 mmol/mol(≥11.0%)(N = 147)
Model 1 73 (0.7) 74 (0.6) 78 (1.1)b 80 (1.4)b
Model 2 73 (0.7) 75 (0.6) 77 (1.0)b 79 (1.3)b
Model 3 73 (0.6) 75 (0.7)a 78 (1.0)b 78 (1.6)a
Model 4 73 (0.6) 75 (0.7)a 78 (1.0)b 78 (1.6)a
Model 5 73 (0.8) 75 (0.6)a 78 (1.0)b 79 (1.6)a
Model 6 73 (0.7) 75 (0.6)a 78 (1.2)b 79 (1.6)b

Heart rate means are determined using predictive margins regression.

HbA1c less than 7.0% is the reference.

Abbreviations: HbA1c, hemoglobin A1c; NHANES, National Health and Nutrition Examination Survey.

a P less than .05 vs HbA1c less than 7.0%.

b P less than .001 vs HbA1c less than 7.0%.

Model 1: Adjusted for time of examination.

Model 2: Additionally adjusted for age.

Model 3: Additionally adjusted for sex, race/ethnicity, education, and poverty income ratio.

Model 4: Additionally adjusted for health insurance.

Model 5: Additionally adjusted smoking, sleep, work, or leisure time activity, body mass index, waist circumference, menopausal status (women only), history of cardiovascular disease, kidney disease, and for hypertensive medication.

Model 6: Additionally adjusted for oral antidiabetic medications (glucagon-like peptide 1 receptor agonist, sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidindiones).